Subscribe To
APLIF / Appili Therapeutics' shares soar on FDA approval for Llikmez oral antibiotic
Content Topics
Appili
Therapeutics
Shares
Soar
Approval
Llikmez
Oral
Therapeutics
Antibiotic
Stock
APLIF
APLIF News
By Proactive Investors
September 25, 2023
Appili Therapeutics' shares soar on FDA approval for Llikmez oral antibiotic
Appili Therapeutics Inc (TSX-V:APLI) shares rallied after it announced the US Food and Drug Administration (FDA) approved its application for a liquid more_horizontal
By Benzinga
October 5, 2021
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral the more_horizontal
By Benzinga
October 5, 2021
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral the more_horizontal
By Benzinga
October 5, 2021
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral the more_horizontal
By Benzinga
October 5, 2021
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral the more_horizontal
By Benzinga
October 5, 2021
Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Aditxt Inc (NASDAQ: ADTX) has agreed to acquire AiPharma Global Holdings LLC, focused on discovering, developing, and commercializing antiviral the more_horizontal